Anthony G. Quinn - 31 Dec 2021 Form 5 Insider Report for Aeglea BioTherapeutics, Inc. (SYRE)

Role
President & CEO, Director
Signature
/s/ James Kastenmayer, by power of attorney
Issuer symbol
SYRE
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
14 Feb 2022, 16:19:58 UTC
Previous filing
13 Dec 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGLE Common Stock Gift $0 -57,450 -15% $0.000000 328,795 28 Dec 2018 Direct
transaction AGLE Common Stock Gift $0 +57,450 $0.000000 57,450 28 Dec 2018 See footnote F1
transaction AGLE Common Stock Gift $0 -175,036 -35% $0.000000 328,795 14 Oct 2021 Direct
transaction AGLE Common Stock Gift $0 +175,036 +518% $0.000000 208,845 14 Oct 2021 See footnote F2
transaction AGLE Common Stock Gift $0 -23,809 -6.8% $0.000000 328,795 18 Oct 2021 Direct
transaction AGLE Common Stock Gift $0 +23,809 +13% $0.000000 208,845 18 Oct 2021 See footnote F2
transaction AGLE Common Stock Gift $0 -10,000 -3% $0.000000 328,795 20 Oct 2021 Direct
transaction AGLE Common Stock Gift $0 +10,000 +5% $0.000000 208,845 20 Oct 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the Anthony G. Quinn Irrevocable Trust of 2018, of which the Reporting Person's spouse is trustee.
F2 These securities are held by the Quinn Family Irrevocable Trust of 2021, of which the Reporting Person's spouse is trustee.